Your browser doesn't support javascript.
loading
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.
Barriuso, Jorge; Nagaraju, Raghavendar T; Belgamwar, Shreya; Chakrabarty, Bipasha; Burghel, George J; Schlecht, Helene; Foster, Lucy; Kilgour, Elaine; Wallace, Andrew J; Braun, Michael; Dive, Caroline; Evans, D Gareth; Bristow, Robert G; Saunders, Mark P; O'Dwyer, Sarah T; Aziz, Omer.
Affiliation
  • Barriuso J; Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom. jorge.barriuso@manchester.ac.uk omer.aziz@manchester.ac.uk.
  • Nagaraju RT; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
  • Belgamwar S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Chakrabarty B; Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Burghel GJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
  • Schlecht H; Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Foster L; Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Kilgour E; Department of Pathology, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • Wallace AJ; NW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
  • Braun M; NW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
  • Dive C; Department of Pathology, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
  • Evans DG; Cancer Research UK Manchester Institute, Cancer Biomarker Centre, University of Manchester, Manchester, England, United Kingdom.
  • Bristow RG; NW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
  • Saunders MP; Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
  • O'Dwyer ST; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
  • Aziz O; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
Clin Cancer Res ; 27(4): 1119-1130, 2021 02 15.
Article de En | MEDLINE | ID: mdl-33257424
ABSTRACT

PURPOSE:

At diagnosis, colorectal cancer presents with synchronous peritoneal metastasis in up to 10% of patients. The peritoneum is poorly characterized with respect to its superspecialized microenvironment. Our aim was to describe the differences between peritoneal metastases and their matched primary tumors excised simultaneously at the time of surgery. Also, we tested the hypothesis of these differences being present in primary colorectal tumors and having prognostic capacity. EXPERIMENTAL

DESIGN:

We report a comprehensive analysis of 30 samples from peritoneal metastasis with their matched colorectal cancer primaries obtained during cytoreductive surgery. We tested and validated the prognostic value of our findings in a pooled series of 660 colorectal cancer primary samples with overall survival (OS) information and 743 samples with disease-free survival (DFS) information from publicly available databases.

RESULTS:

We identified 20 genes dysregulated in peritoneal metastasis that promote an early increasing role of "stemness" in conjunction with tumor-favorable inflammatory changes. When adjusted for age, gender, and stage, the 20-gene peritoneal signature proved to have prognostic value for both OS [adjusted HR for the high-risk group (vs. low-risk) 2.32 (95% confidence interval, CI, 1.69-3.19; P < 0.0001)] and for DFS [adjusted HR 2.08 (95% CI, 1.50-2.91; P < 0.0001)].

CONCLUSIONS:

Our findings indicated that the activation of "stemness" pathways and adaptation to the peritoneal-specific environment are key to early stages of peritoneal carcinomatosis. The in silico analysis suggested that this 20-gene peritoneal signature may hold prognostic information with potential for development of new precision medicine strategies in this setting.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cavité péritonéale / Tumeurs du péritoine / Cellules souches tumorales / Tumeurs colorectales / Récidive tumorale locale Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cavité péritonéale / Tumeurs du péritoine / Cellules souches tumorales / Tumeurs colorectales / Récidive tumorale locale Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article